Newsletter Tool

To view this email as a web page, click here

This week's sponsor is Premier Research.
	ICH GCP guideline updates. Looking for the best insights? The ICH Good Clinical Practice guidelines have been updated to reflect profound changes in how clinical trials run. Our white paper covers what you need to know. Premier Research. It's what we do. Best.

Today's Rundown

Featured Story

Redx pauses WNT cancer trial after first patient suffers adverse events

Thursday, March 29, 2018

Redx has hit pause on a phase 1/2a trial of its porcupine inhibitor after the first patient to receive the drug suffered “clinically significant” adverse events. The blow continues a rotten run for Redx, which spent half of last year fighting to resolve a debt crisis.

This week's sponsor is Victorian Government Business Office
	[Webinar] Fast, Quality Clinical Trials for Less: Let Melbourne, Australia be your Partner Tuesday, April 10 \| 4pm ET / 1pm PT This webinar will help you understand how Melbourne and its world-class clinical network can help your company get your studies up and running faster, at lower cost with better results than anywhere else around the world. Register Now!

Unum IPO hits bottom of range, netting $62M for cell therapy cancer trials

Thursday, March 29, 2018

Unum Therapeutics has netted $62 million in a Nasdaq IPO. The total falls short of the amount Unum set out to raise but leaves the biotech with enough cash to advance two cell therapy candidates in four clinical trials.

MediciNova's repurposed stroke drug flops in methamphetamine dependence trial

Thursday, March 29, 2018

MediciNova's repurposed stroke and asthma drug ibudilast missed its primary endpoint of methamphetamine abstinence in a 12-week phase 2 trial.

[Sponsored] Highlighting Women Pioneers in Science & Medicine

Monday, March 26, 2018

As leaders in science and business, two high-profile female CEOs have been instrumental in advancing medical breakthroughs and are champions for issues that affect women around the world.

U.K. biotech C4XD leaps on $294M addiction drug deal with Indivior

Thursday, March 29, 2018

Shares in U.K. biotech C4X Discovery almost doubled today after Reckitt Benkiser spinout Indivior agreed a $294 million deal for a drug candidate to treat addiction.

Mitsubishi Tanabe, Hitachi join forces in AI-enabled clinical trials

Thursday, March 29, 2018

Through a new collaboration, Mitsubishi Tanabe Pharma will apply Hitachi’s artificial intelligence technology to make clinical trials more efficient and to drive down drug development costs.

Abbott backs Bigfoot, bringing series B haul up to $55M

Thursday, March 29, 2018

Abbott has participated in diabetes startup Bigfoot Biomedical’s series B round. The involvement of Abbott and other investors means Bigfoot has $55 million to take its insulin pump and pen through clinical development and onto the market.

This week's sponsor is Veeva.

[Survey] Veeva 2018 Unified Clinical Operations Survey

Please take a moment to share your thoughts in this 15-minute survey which examines the life sciences industry's progress in reducing system and process complexity to improve study execution.

Take the Survey Now for a chance to win a $50 Amazon gift card!

Resources

[Whitepaper] Compliance Certificate and Training for Life Sciences Professionals

[Whitepaper] Digitizing the Global Life Sciences Supply Chain: The Critical Role of Digital Transaction Management

[Whitepaper] Medical Device Innovation: Are You Outrunning The Competition?

[Whitepaper] Choosing the Right Solution: Improving the Site Feasibility Process

[Whitepaper] How Do Sponsors Ensure Quality in Global Clinical Trials?

Presented by: Covance

Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives.